Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

TAKHLN

Takeda Pharmaceutical Company Limited

Area by area

Overall Quant Score

How does it look overall? (out of 100)

TAK

63/100

HLN

54/100

Quality

Is it a profitable, well-run business?

TAK

2.1/10

HLN

4.4/10

Growth

Is the company growing?

TAK

4.5/10

HLN

3.0/10

Valuation

Is the price reasonable? (higher = cheaper)

TAK

6.9/10

HLN

6.6/10

Risk

How risky are the shares? (higher = lower risk)

TAK

6.9/10

HLN

7.2/10

Momentum

Is the share price trending up?

TAK

8.4/10

HLN

7.5/10

Financial strength

Is the balance sheet healthy?

TAK

2.8/10

HLN

5.2/10

The balanced view

Model-generated

Takeda Pharmaceutical Company Limited

This company scores above average, with supportive analyst views and a positive price trend, although its profitability is thin.

Leads on: growth, valuation, momentum

Best feature: analysts broadly positive (Analyst buy share: 83%)

Watch out: profitability is thin (Return on equity (TTM): 2.4%)

Haleon plc

This company has a mixed profile, with a positive price trend and a relatively low-risk profile, although its growth has been slow.

Leads on: quality, risk, financial strength

Best feature: positive price trend (MACD histogram: 0.12)

Watch out: growth is slow or negative (Revenue CAGR (3Y): 0.5%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.